UPDATE: Elevance Health shares tick up on better-than-expected earnings
Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market trading Thursday. Shares of Elevance gained more than 4% to $408 a share before the bell.
Elevance Health: Q4 Earnings Snapshot
The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The average estimate of 17 analysts surveyed by Zacks Investment Research was for earnings of $3.80 per share.
Elevance Health earnings boost health-insurance stocks after upbeat outlook
Elevance Health Inc.’s stock jumped 5% in premarket trade Thursday and boosted other health insurance stocks, after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns after a big miss in the third quarter.
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.
Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond
Health Care Up as Elevance Rises on Earnings -- Health Care Roundup
Elevance Health, the health insurer formerly known as Anthem, posted fourth-quarter profit and revenue ahead of Wall Street targets, and forecast more gains from premiums and products in the year ahead.
Elevance Earnings: Stock Rises After Results, Guidance Match Expectations
Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results marked t
Elevance Health Stock Rises On Upbeat Q4 Revenue, Dividend Boost: Retail's Over The Moon
Shares of Elevance Health Inc. climbed over 2.5% on Thursday morning, hitting levels last seen in early December. The rise came as the health insurer reported better-than-expected fourth-quarter results and provided an upbeat outlook for 2025.
Forbes26d
Elevance Health Bolsters Anthem Portfolio, Closes Indiana University Health Plans Deal
Elevance Health closed its acquisition of Indiana ... including Indiana where the company’s headquarters sits in Indianapolis. IU Health is primarily an operator of hospitals and other ...
Ibj.com27d
Elevance completes IU Health Plans acquisition
As the year ended, Indianapolis-based health insurance giant Elevance Health completed its previously announced acquisition of Indiana University Health Plans, the managed care unit of ...
Benefits Pro3d
Elevance is glad it raised commercial health insurance prices for 2025
Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...
Elevance Health Raises Quarterly Dividend by 4.9% to $1.71
Elevance Health's board has raised the health insurer and healthcare-services provider's quarterly dividend by 4.9%, to $1.71 from $1.63. The new payout, equal to $6.84 a year, represents an annual ...
Hosted on MSN1mon
Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell?
Elevance Health, headquartered in Indianapolis, IN, has a market capitalization of $84.9 billion. Its peers, UnitedHealth Group Incorporated UNH and The Cigna Group CI, have also declined during ...
Becker's Hospital Review25d
IU Health sells health plan to Elevance
Indianapolis-based Indiana University Health completed the sale of its health plan to Elevance Health on Dec. 31. IU Health Plans serves 19,000 Medicare Advantage members across 36 ...
Elevance Health: Attractive Valuation and Stable Growth Prospects Drive Buy Rating
Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...